Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Cannula Market by Product (Nasal Cannula, Vascular Cannula, Venous Cannula, Cardiac Cannula, Arthroscopy Cannula, Intravenous Cannula, Dermatology Cannula,, Others) , by Application (Orthopedics Surgery, General Surgery, Cardiovascular Surgery, Plastic Surgery, Oxygen Therapy, Others) by End User (Hospitals, Clinics, Ambulatory Surgery Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A07071

Pages: 320

Charts: 68

Tables: 148

Cannula Market Research, 2033

The global cannula market size was valued at $171.9 million in 2023, and is projected to reach $316.9 million by 2033, growing at a CAGR of 6.7% from 2024 to 2033.

Market Definition and Overview

A cannula is a medical device that consists of a thin tube inserted into the body for the delivery or removal of fluids, medications, or gases. Cannulas are commonly used in various medical procedures, including intravenous (IV) therapy, anesthesia administration, blood transfusions, and drainage of fluids from the body. The design of a cannula can vary depending on its intended use. Some cannulas have a sharp, pointed tip for piercing through tissues, while others have a blunt tip for safer insertion into delicate areas. They are typically made of materials such as plastic, metal, or silicone.

Cannulas are used in both clinical settings, such as hospitals and healthcare facilities, and in home healthcare settings. They play a crucial role in providing patients with necessary medications, fluids, or treatments, as well as assisting in diagnostic and therapeutic procedures.

Key Takeaways

  • The cannula market forecast study covers 20 countries. The research includes a segment analysis of each country in terms of value ($million) for the projected period from 2024 to 2033.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major cannula industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Product
    • Nasal Cannula
    • Vascular Cannula
    • Venous Cannula
    • Cardiac Cannula
    • Arthroscopy Cannula
    • Intravenous Cannula
    • Dermatology Cannula,
    • Others
  • By Application
    • Orthopedics Surgery
    • General Surgery
    • Cardiovascular Surgery
    • Plastic Surgery
    • Oxygen Therapy
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of LAMEA

 
Key Market Players

  • Flexicare Medical
  • Edward Lifesciences
  • LivaNova
  • Becton Dickinson (BD)
  • Boston Scientific Corporation
  • Medtronic
  • Terumo Corporation
  • Fisher & Paykel Healthcare Ltd
  • Medin Medical Innovations
  • Smiths Medical

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: CANNULA MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Nasal Cannula

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Vascular Cannula

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Venous Cannula

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Cardiac Cannula

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Arthroscopy Cannula

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Intravenous Cannula

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Dermatology Cannula,

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

    • 4.9. Others

      • 4.9.1. Key Market Trends, Growth Factors and Opportunities

      • 4.9.2. Market Size and Forecast, By Region

      • 4.9.3. Market Share Analysis, By Country

  • CHAPTER 5: CANNULA MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Orthopedics Surgery

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. General Surgery

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cardiovascular Surgery

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Plastic Surgery

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Oxygen Therapy

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Others

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: CANNULA MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Ambulatory Surgery Centers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: CANNULA MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Cannula Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Cannula Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Cannula Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Cannula Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Cannula Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Cannula Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Cannula Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Cannula Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Cannula Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Cannula Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Cannula Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Cannula Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Cannula Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Cannula Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Cannula Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Cannula Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Cannula Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Cannula Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Cannula Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Cannula Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Cannula Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Cannula Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Cannula Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Cannula Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Cannula Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Medtronic

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Becton Dickinson (BD)

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Edward Lifesciences

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. LivaNova

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Smiths Medical

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Boston Scientific Corporation

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Terumo Corporation

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Fisher And Paykel Healthcare Ltd

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Flexicare Medical

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Medin Medical Innovations

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CANNULA MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL CANNULA MARKET FOR NASAL CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL CANNULA MARKET FOR VASCULAR CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL CANNULA MARKET FOR VENOUS CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL CANNULA MARKET FOR CARDIAC CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL CANNULA MARKET FOR ARTHROSCOPY CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL CANNULA MARKET FOR INTRAVENOUS CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL CANNULA MARKET FOR DERMATOLOGY CANNULA,, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL CANNULA MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL CANNULA MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL CANNULA MARKET FOR ORTHOPEDICS SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL CANNULA MARKET FOR GENERAL SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL CANNULA MARKET FOR CARDIOVASCULAR SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL CANNULA MARKET FOR PLASTIC SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL CANNULA MARKET FOR OXYGEN THERAPY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL CANNULA MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL CANNULA MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL CANNULA MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. GLOBAL CANNULA MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. GLOBAL CANNULA MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. GLOBAL CANNULA MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 22. GLOBAL CANNULA MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. NORTH AMERICA CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 24. NORTH AMERICA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. NORTH AMERICA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. NORTH AMERICA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. U.S. CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. U.S. CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. U.S. CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 30. CANADA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. CANADA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. CANADA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. MEXICO CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. MEXICO CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. MEXICO CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 36. EUROPE CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 37. EUROPE CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. EUROPE CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. EUROPE CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. FRANCE CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. FRANCE CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. FRANCE CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. GERMANY CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. GERMANY CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. GERMANY CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. ITALY CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. ITALY CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. ITALY CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. SPAIN CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. SPAIN CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. SPAIN CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. UK CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. UK CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. UK CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 55. RUSSIA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. RUSSIA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. RUSSIA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. REST OF EUROPE CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 59. REST OF EUROPE CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. REST OF EUROPE CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. ASIA-PACIFIC CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 62. ASIA-PACIFIC CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. ASIA-PACIFIC CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. ASIA-PACIFIC CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. CHINA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. CHINA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. CHINA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. JAPAN CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. JAPAN CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. JAPAN CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. INDIA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 72. INDIA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. INDIA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. SOUTH KOREA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. SOUTH KOREA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. SOUTH KOREA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. AUSTRALIA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 78. AUSTRALIA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. AUSTRALIA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. THAILAND CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 81. THAILAND CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 82. THAILAND CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 83. MALAYSIA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 84. MALAYSIA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 85. MALAYSIA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 86. INDONESIA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 87. INDONESIA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 88. INDONESIA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 89. REST OF ASIA PACIFIC CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 90. REST OF ASIA PACIFIC CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. REST OF ASIA PACIFIC CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 92. LAMEA CANNULA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 93. LAMEA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 94. LAMEA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. LAMEA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. BRAZIL CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 97. BRAZIL CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. BRAZIL CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 99. SOUTH AFRICA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 100. SOUTH AFRICA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 101. SOUTH AFRICA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 102. SAUDI ARABIA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 103. SAUDI ARABIA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. SAUDI ARABIA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 105. UAE CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 106. UAE CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 107. UAE CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 108. ARGENTINA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 109. ARGENTINA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 110. ARGENTINA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 111. REST OF LAMEA CANNULA, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 112. REST OF LAMEA CANNULA, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 113. REST OF LAMEA CANNULA, BY END USER, 2025-2033 ($MILLION)
  • TABLE 114. MEDTRONIC: KEY EXECUTIVES
  • TABLE 115. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 116. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 117. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 118. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. BECTON DICKINSON (BD): KEY EXECUTIVES
  • TABLE 120. BECTON DICKINSON (BD): COMPANY SNAPSHOT
  • TABLE 121. BECTON DICKINSON (BD): OPERATING SEGMENTS
  • TABLE 122. BECTON DICKINSON (BD): PRODUCT PORTFOLIO
  • TABLE 123. BECTON DICKINSON (BD): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. EDWARD LIFESCIENCES: KEY EXECUTIVES
  • TABLE 125. EDWARD LIFESCIENCES: COMPANY SNAPSHOT
  • TABLE 126. EDWARD LIFESCIENCES: OPERATING SEGMENTS
  • TABLE 127. EDWARD LIFESCIENCES: PRODUCT PORTFOLIO
  • TABLE 128. EDWARD LIFESCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. LIVANOVA: KEY EXECUTIVES
  • TABLE 130. LIVANOVA: COMPANY SNAPSHOT
  • TABLE 131. LIVANOVA: OPERATING SEGMENTS
  • TABLE 132. LIVANOVA: PRODUCT PORTFOLIO
  • TABLE 133. LIVANOVA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. SMITHS MEDICAL: KEY EXECUTIVES
  • TABLE 135. SMITHS MEDICAL: COMPANY SNAPSHOT
  • TABLE 136. SMITHS MEDICAL: OPERATING SEGMENTS
  • TABLE 137. SMITHS MEDICAL: PRODUCT PORTFOLIO
  • TABLE 138. SMITHS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 140. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 141. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 142. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 143. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. TERUMO CORPORATION: KEY EXECUTIVES
  • TABLE 145. TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 146. TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 147. TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 148. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. FISHER AND PAYKEL HEALTHCARE LTD: KEY EXECUTIVES
  • TABLE 150. FISHER AND PAYKEL HEALTHCARE LTD: COMPANY SNAPSHOT
  • TABLE 151. FISHER AND PAYKEL HEALTHCARE LTD: OPERATING SEGMENTS
  • TABLE 152. FISHER AND PAYKEL HEALTHCARE LTD: PRODUCT PORTFOLIO
  • TABLE 153. FISHER AND PAYKEL HEALTHCARE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. FLEXICARE MEDICAL: KEY EXECUTIVES
  • TABLE 155. FLEXICARE MEDICAL: COMPANY SNAPSHOT
  • TABLE 156. FLEXICARE MEDICAL: OPERATING SEGMENTS
  • TABLE 157. FLEXICARE MEDICAL: PRODUCT PORTFOLIO
  • TABLE 158. FLEXICARE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. MEDIN MEDICAL INNOVATIONS: KEY EXECUTIVES
  • TABLE 160. MEDIN MEDICAL INNOVATIONS: COMPANY SNAPSHOT
  • TABLE 161. MEDIN MEDICAL INNOVATIONS: OPERATING SEGMENTS
  • TABLE 162. MEDIN MEDICAL INNOVATIONS: PRODUCT PORTFOLIO
  • TABLE 163. MEDIN MEDICAL INNOVATIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CANNULA MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CANNULA MARKET
  • FIGURE 3. SEGMENTATION CANNULA MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CANNULA MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCANNULA MARKET
  • FIGURE 11. CANNULA MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. CANNULA MARKET FOR NASAL CANNULA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. CANNULA MARKET FOR VASCULAR CANNULA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. CANNULA MARKET FOR VENOUS CANNULA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. CANNULA MARKET FOR CARDIAC CANNULA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. CANNULA MARKET FOR ARTHROSCOPY CANNULA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. CANNULA MARKET FOR INTRAVENOUS CANNULA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. CANNULA MARKET FOR DERMATOLOGY CANNULA,, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. CANNULA MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. CANNULA MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 21. CANNULA MARKET FOR ORTHOPEDICS SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. CANNULA MARKET FOR GENERAL SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. CANNULA MARKET FOR CARDIOVASCULAR SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. CANNULA MARKET FOR PLASTIC SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. CANNULA MARKET FOR OXYGEN THERAPY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. CANNULA MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. CANNULA MARKET SEGMENTATION, BY BY END USER
  • FIGURE 28. CANNULA MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 29. CANNULA MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 30. CANNULA MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 31. CANNULA MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 36. COMPETITIVE DASHBOARD
  • FIGURE 37. COMPETITIVE HEATMAP: CANNULA MARKET
  • FIGURE 38. TOP PLAYER POSITIONING, 2024
  • FIGURE 39. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. BECTON DICKINSON (BD): NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. BECTON DICKINSON (BD): REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. BECTON DICKINSON (BD): REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. EDWARD LIFESCIENCES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. EDWARD LIFESCIENCES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. EDWARD LIFESCIENCES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. LIVANOVA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. LIVANOVA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. LIVANOVA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. SMITHS MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. TERUMO CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 60. FISHER AND PAYKEL HEALTHCARE LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 61. FISHER AND PAYKEL HEALTHCARE LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 62. FISHER AND PAYKEL HEALTHCARE LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 63. FLEXICARE MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 64. FLEXICARE MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 65. FLEXICARE MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 66. MEDIN MEDICAL INNOVATIONS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 67. MEDIN MEDICAL INNOVATIONS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 68. MEDIN MEDICAL INNOVATIONS: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Cannula Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved